IP Verse

Curevac Se patent opposition analysis

Latest patents of Curevac Se opposed by its competitors

The following table provides an overview of the latest patents of Curevac Se that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP4023755Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3708668Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3115064Nov 24, 2021Rna-Coded Antibody1
EP3297682Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2
EP3298142Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2
EP3294326Apr 21, 2021Prime-Boost Regimens Involving Administration Of At Least One Mrna Construct1
EP3062798May 6, 2020Modified Rna With Decreased Immunostimulatory Properties2
EP3116535Aug 7, 2019Combination Of Vaccination And Ox40 Agonists1
EP3173092Jun 26, 2019Rna Containing Composition For Treatment Of Tumor Diseases5
EP3326641Jun 26, 2019Rna Containing Composition For Treatment Of Tumor Diseases4

Top competitors of Curevac Se